“Anakinra as Rescue Therapy to Treat Patients with Severe COVID-19 Refractory to Tocilizumab” (2021) Archives of Clinical and Biomedical Research, 5(6), pp. 972–982. Available at: https://www.fortunejournals.org/ojs/index.php/acbr/article/view/14882 (Accessed: 20 September 2026).